Skip to content

Modified Thoracolumbar Interfascial Plane Block vs Retrolaminar Block for Pain in Lumbar Spine Surgeries

Effect of Modified Thoracolumbar Interfascial Plane Block Versus Retrolaminar Block for Pain Control in Postoperative Lumbar Spine Surgeries: A Prospective Randomized Double-Blind Clinical Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07883616
Enrollment
42
Registered
2026-10-20
Start date
2025-10-01
Completion date
2027-01-01
Last updated
2026-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain After Spinal Surgery

Brief summary

This prospective randomized double-blind study aims to compare the efficacy of modified Thoracolumbar Interfascial Plane (mTLIP) block versus Retrolaminar block for postoperative pain control in patients undergoing elective two-level lumbar spine surgeries. The primary outcome is total morphine consumption in the first 24 postoperative hours.

Detailed description

Pain after lumbar spine surgery arises from disruption of paraspinal muscles, ligaments, and bony structures, with innervation from dorsal rami of spinal nerves. Opioids remain the cornerstone of postoperative analgesia but carry adverse effects. The mTLIP block targets the fascial plane between longissimus and iliocostalis muscles, while the Retrolaminar block deposits local anesthetic on the posterior surface of the vertebral lamina. Both target the dorsal rami. This study will compare both techniques regarding opioid consumption, pain scores, time to first rescue analgesia, block performance metrics, side effects, functional recovery, and patient satisfaction.

Interventions

DRUGMorphine

Rescue analgesic administered intravenously at a dose of 0.1-0.2 mg/kg every 2-4 hours as needed for breakthrough pain (NRS \> 3), with a maximum dose of 10 mg per administration.

DRUGBupivacaine

Local anesthetic used in the block solution (0.25%, 15 mL per side).

DRUGDexamethasone

Adjuvant added to the block solution (8 mg per side) to prolong analgesia.

DRUGMagnesium Sulphate

Adjuvant added to the block solution (300 mg of 10% per side) to prolong analgesia.

Ultrasound-guided injection between the longissimus and iliocostalis muscles at the L3 level.

Ultrasound-guided injection on the posterior surface of the vertebral lamina at the L3 level, deep to the erector spinae muscles.

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The patient and the outcome assessor are blinded to group allocation. The anesthesiologist performing the block is not blinded.

Intervention model description

Participants are randomized into two parallel groups. Group M receives modified Thoracolumbar Interfascial Plane block, and Group R receives Retrolaminar block, both followed by standardized general anesthesia.

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age between 21 and 65 years * ASA physical status I or II * BMI \< 30 kg/m² * Scheduled for elective two-level lumbar spine surgery (discectomy/decompression) * Expected duration of surgery less than 3 hours * Patient's acceptance and written informed consent

Exclusion criteria

* Infection at block site * Known allergy to used drugs * Coagulation disorder * History of psychiatric illness * Pre-existing neurological deficits * Presence of any metastasis * Previous lumbar spine surgeries * Patients on previous opioid therapy

Design outcomes

Primary

MeasureTime frameDescription
Total morphine consumption in the first 24 hours postoperatively24 hours postoperativelyCumulative morphine dose (mg) administered as rescue analgesia during the first 24 postoperative hours

Secondary

MeasureTime frameDescription
Pain intensity by Numerical Rating Scale (NRS)At 2, 4, 8, 12, 18, and 24 hours postoperativelyPain intensity assessed using a 10-point Numerical Rating Scale (0 = no pain, 10 = worst pain imaginable)
Time to first rescue analgesiaFirst 24 hours postoperativelyTime from local anesthetic injection until the patient first requests additional pain-relieving medication (NRS \> 3)
Block performance timeDuring block procedureTime required to perform the block procedure
Onset of sensory blockWithin 20-30 minutes after injectionTime from local anesthetic injection until loss of sensation in the desired dermatomes
Opioid-related side effects24 hours postoperativelyIncidence of postoperative nausea and vomiting (PONV) assessed by PONV impact scale (0 = none, 1 = mild, 2 = moderate, 3 = severe), sedation, and respiratory depression
Patient satisfaction score24 hours postoperativelyPatient satisfaction assessed using a 4-point scale (4 = excellent, 3 = good, 2 = fair, 1 = poor)
Incidence of chronic pain3 to 6 months postoperativelyChronic pain will be assessed at 3 months postoperatively via a structured follow-up (telephone interview or outpatient clinic visit). Patients will be asked whether they experience persistent or recurrent pain at or around the surgical site lasting more than 3 months after surgery. Responses will be recorded as "Yes" or "No," and the proportion of patients answering "Yes" will be reported as the incidence of chronic pain, according to the IASP definition (pain persisting or recurring for more than 3 months).
Time of ambulationFirst 24 hours postoperativelyTime to first mobilization after surgery

Countries

Egypt

Contacts

CONTACTMohamed Shehta Mohamed Ali
m.shehta025@medicine.zu.edu.eg+2001014634299
PRINCIPAL_INVESTIGATORMohamed Shehta Mohamed Ali, M.B.B.CH

Zagazig University

STUDY_CHAIRTarek Gaafar, Prof

Zagazig University

STUDY_CHAIRSanaa Eltohamy, Prof

Zagazig University

STUDY_CHAIRKhadeja Elhossieny, Assist Prof

Zagazig University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Oct 21, 2026